Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sales of the immuno-inflammation drug Benlysta were up 12% driven by strong demand and volume growth in all regions. Benlysta sales benefited from bio penetration growth from earlier intervention ...

The company thanks the new drug could also make sales of $1 billion or more, as it has the potential to be used in people with less severe SLE than Benlysta, although Evaluate Pharma has a more ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Group sales fell 4 per cent to £5.6 billion ($ ... There were positive signs for GSK in the form of lupus treatment Benlysta (belimumab), which grew 21 per cent to £41 million and Promacta ...

A Tesla store in Colma, California, on Monday, March 10, 2025. Shah is a reporter at TIME. Tesla sales have been faltering worldwide as consumers push back against the company’s CEO Elon Musk ...

Not long ago, two colleagues and I found ourselves in an online meeting, cornered by three wildly overzealous sales professionals. They were selling a tool my company was evaluating, and their ...

Benlysta starts working right away, but it may take time for you to see improvements in your symptoms. Some people started to see improvements after 8 weeks. Benlysta starts working right away ...